New York, Aug. 11, 2020 (GLOBE NEWSWIRE) -- The Global Amniocentesis Needle Market is expected to reach USD 211.7 Million by 2027, according to a new report by Reports and Data. Amniocentesis needle is used for insertion into the amniotic sac in the abdomen of a pregnant woman to extract a small amount of the amniotic fluid for the purpose of diagnosis. The amniotic fluid consists of cells that possess genetic information about the fetus. Amniocentesis procedure is beneficial in establishing a provisional diagnosis of the presence of a disorder or abnormality detected in other tests. Besides, the procedure also confirms that a fetus is not at the risk of suspected defect, thereby aiding in the planning of further pregnancy or other suitable alternatives.
The growing burden of congenital anomalies is an important factor in fuelling market growth. Congenital anomalies/disorders are a major reason for premature death, birth asphyxia, pregnancy loss, and long-lasting disability contribute significantly to morbidity and mortality in newborn babies. It has been estimated that 7.9 million babies are born with significant congenital disorders. Congenital cardiovascular disorder is a swiftly evolving issue in child health around the world and requires interventions to increase survival and life-quality. Over 90.0% of congenital disorders take place in low and middle-income countries.
Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/3405
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on healthcare providers and patients and has posed problems in practice pertaining to prenatal care, such as diagnosis and therapy of the fetus. Coronavirus infection during pregnancy may cause the risk of premature birth or hindered the growth of the fetus. Hence, recommendations are made for the examination of amniotic fluid, among other tests, which, in turn, is likely to have a positive impact on the market demand.
Further key findings from the report suggest
- By needle size, a 100-150 mm needle contributed to the largest market share in 2019 attributed to the growing necessity for the removal of excess of amniotic fluid and the widespread use of these kinds of needles owing to their suitable length and appropriateness of usage in several patients.
- By procedure, amnioinfusion is likely to grow at a significant rate in the forecast period, owing to the offering of advantages such as diluting the thick meconium clumps by the instilled fluid and likely deterrence of cord compression. Nevertheless, amnioinfusion is not considered advantageous in meconium-related neonatal illness.
- By application, diagnostic centers are projected to grow at the fastest rate of xx% in the forecast period. A diagnostic center offers extensive expertise, as well as experienced staff in performing the amniocentesis diagnosis, which is used for detecting substantial issues related to chromosome, including Down syndrome, along with missing bits of chromosomes.
- North America dominated the market in 2019 and is likely to grow at a rate of 2.0% in the forecast period. The market dominance of the region is owing to the high disposable income, high level of awareness about the procedure, and well-established healthcare facilities.
- Key participants include Becton, Dickinson and Company, Smiths Medical, Medtronic, CooperSurgical, Integra Lifesciences, Cook Medical, Medline, Biopsybell, RI. MOS, Laboratoire CCD, among others.
- In October 2019, Medtronic PLC made an announcement about building an Innovation Center in Chengdu (China). The innovation center is set to commence in 2020 and offer a platform for foremost, cross-disciplinary medical research and training for medical workers in the region.
BUY NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.reportsanddata.com/checkout-form/3405
For the purpose of this report, Reports and Data has segmented the Global Amniocentesis Needle Market on the basis of needle size, procedure, end-user, and region:
Needle Size Outlook (Revenue, USD Million; 2017-2027)
- Smaller than 100 mm
- 100 – 150 mm
- Larger than 150 mm
Procedure Outlook (Revenue, USD Million; 2017-2027)
- Amniocentesis
- Amnioreduction
- Fetal Blood Transfusion
- Amnioinfusion
- Others
End-User Outlook (Revenue, USD Million; 2017-2027)
- Hospitals
- Diagnostic Centers
- Clinics
- Others
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/amniocentesis-needle-market
Regional Outlook (Revenue, USD Million; 2017-2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- Rest of MEA
Take a Look at our Related Reports:
Bio-Based Resins Market: https://www.reportsanddata.com/report-detail/bio-based-resins-market
Acrylonitrile Butadine Styrene Market: https://www.reportsanddata.com/report-detail/acrylonitrile-butadiene-styrene-abs-market
Bio-Based Polyurethane Market: https://www.reportsanddata.com/report-detail/bio-based-polyurethane-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.